214 related articles for article (PubMed ID: 8649791)
1. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines.
Algar EM; Khromykh T; Smith SI; Blackburn DM; Bryson GJ; Smith PJ
Oncogene; 1996 Mar; 12(5):1005-14. PubMed ID: 8649791
[TBL] [Abstract][Full Text] [Related]
2. [Effect of WT1 antisense oligonucleotide on proliferation and apoptosis of human leukemia cells].
Wu X; Wang Y; Pei X
Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):631-3. PubMed ID: 11721364
[TBL] [Abstract][Full Text] [Related]
3. [Effect of WT1 gene expression on cell growth and proliferation in myeloid leukemia cell lines].
Mi Y; Wang L; Bian S
Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):627-30. PubMed ID: 11263329
[TBL] [Abstract][Full Text] [Related]
4. Effect of WT1 gene expression on cell growth and proliferation in myeloid leukemia cell lines.
Mi Y; Wang L; Bian S; Meng Q; Chen G; Wang J
Chin Med J (Engl); 1999 Aug; 112(8):705-8. PubMed ID: 11601276
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction.
Mahon FX; Ripoche J; Pigeonnier V; Jazwiec B; Pigneux A; Moreau JF; Reiffers J
Exp Hematol; 1995 Dec; 23(14):1606-11. PubMed ID: 8542954
[TBL] [Abstract][Full Text] [Related]
6. Phosphorothioate-capped antisense oligonucleotides to Ras GAP inhibit cell proliferation and trigger apoptosis but fail to downregulate GAP gene expression.
White JR; Gordon-Smith EC; Rutherford TR
Biochem Biophys Res Commun; 1996 Oct; 227(1):118-24. PubMed ID: 8858112
[TBL] [Abstract][Full Text] [Related]
7. Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173.
Smetsers TF; Skorski T; van de Locht LT; Wessels HM; Pennings AH; de Witte T; Calabretta B; Mensink EJ
Leukemia; 1994 Jan; 8(1):129-40. PubMed ID: 8289478
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis.
Yamagami T; Sugiyama H; Inoue K; Ogawa H; Tatekawa T; Hirata M; Kudoh T; Akiyama T; Murakami A; Maekawa T
Blood; 1996 Apr; 87(7):2878-84. PubMed ID: 8639907
[TBL] [Abstract][Full Text] [Related]
9. C/EBPdelta expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation.
Gery S; Tanosaki S; Hofmann WK; Koppel A; Koeffler HP
Oncogene; 2005 Feb; 24(9):1589-97. PubMed ID: 15674331
[TBL] [Abstract][Full Text] [Related]
10. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.
Huang M; Dorsey JF; Epling-Burnette PK; Nimmanapalli R; Landowski TH; Mora LB; Niu G; Sinibaldi D; Bai F; Kraker A; Yu H; Moscinski L; Wei S; Djeu J; Dalton WS; Bhalla K; Loughran TP; Wu J; Jove R
Oncogene; 2002 Dec; 21(57):8804-16. PubMed ID: 12483533
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation.
Cilloni D; Messa F; Gottardi E; Fava M; Arruga F; Defilippi I; Carturan S; Messa E; Morotti A; Giugliano E; Rege-Cambrin G; Alberti D; Baccarani M; Saglio G
Cancer; 2004 Sep; 101(5):979-88. PubMed ID: 15329907
[TBL] [Abstract][Full Text] [Related]
13. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
14. Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels.
Smetsers TF; van de Locht LT; Pennings AH; Wessels HM; de Witte TM; Mensink EJ
Leukemia; 1995 Jan; 9(1):118-30. PubMed ID: 7845006
[TBL] [Abstract][Full Text] [Related]
15. The abnormal p53 proteins expressed in CML cell lines are non-functional.
Bi S; Lanza F; Goldman JM
Leukemia; 1993 Nov; 7(11):1840-5. PubMed ID: 8231251
[TBL] [Abstract][Full Text] [Related]
16. The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells.
Baśkiewicz-Masiuk M; Machaliński B
Eur J Haematol; 2004 Jun; 72(6):420-9. PubMed ID: 15128421
[TBL] [Abstract][Full Text] [Related]
17. [Expression of Wilms' tumor gene (WT1) in leukemias and its clinical implication].
Wu X; Wang Y; Pei X
Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):16-9. PubMed ID: 10921096
[TBL] [Abstract][Full Text] [Related]
18. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
Perrotti D; Cesi V; Trotta R; Guerzoni C; Santilli G; Campbell K; Iervolino A; Condorelli F; Gambacorti-Passerini C; Caligiuri MA; Calabretta B
Nat Genet; 2002 Jan; 30(1):48-58. PubMed ID: 11753385
[TBL] [Abstract][Full Text] [Related]
19. [Antisense human telomerase reverse transcriptase inhibits leukemia cell proliferation in vitro].
Sun LB; Li CR; Wen JM; Wang GB; Zhang M; Yang J; Li RX
Di Yi Jun Yi Da Xue Xue Bao; 2004 May; 24(5):521-4. PubMed ID: 15151822
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
